Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study was to investigate the effect of Fluoride varnish and Casein Phospho-Peptide Amorphous Calcium Phosphate (CPP-ACP) containing paste on oral symptoms and salivary characteristics in patients under chemotherapy.
Chemotherapy as a treatment method of cancers, affects different parts of the oral cavity such as oral mucosa, teeth and salivary glands caused by salivary glands dysfunction during chemotherapy.Oral status of patients under chemotherapy will be affected by consumption of the drugs and their side effects such as reduction of the saliva, dryness of the oral cavity, changes in bacterial balance, oral mucosa damage, bleeding due to irritation of the tissues, xerostomia, dental caries, burning sensation, dysgeusia and dysphagia. No effective preventive protocol has been presented for oral care during chemotherapy.
Patients who were met the inclusion criteria (aged over 12, diagnosed to have cancer by an oncologists and needed chemotherapy drugs, had at least 20 teeth, had no other pathologic lesion in their oral cavity, were not treated by radiotherapy and did not have specific systemic diseases or head and neck cancer) were selected for the study. the participants were evaluated according to oral and salivary symptoms.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Fluoride Varnish | Experimental | Fluoride varnish was used once in this group. Fluoride varnish(NaF 5%,Sultan,USA) |
|
| Oral hygiene | Experimental | Oral hygiene followed twice daily. No F varnish or CPP-ACP applied. |
|
| CPP-ACP | Experimental | CPP-ACP paste (GC Tooth Mousse,Gc,USA)was applied by patients once daily. 3gr,for 42 days. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Fluoride varnish | Drug | Fluoride Varnish (NaF 5%) |
|
|
| Measure | Description | Time Frame |
|---|---|---|
| oral symptoms(mucositis, xerostomia, infection, dysphagia, dysgeusia, burning sensation in mouth. | 6 weeks after first visit |
| Measure | Description | Time Frame |
|---|---|---|
| pH of saliva | 6 weeks after first visit | |
| pH of dental plaque | 6 weeks after first visit | |
| Quantity of saliva ( rest and stimulated) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Sepideh Banava, Assist-Prof | Azad University of Medical Sciences, Dental Branch | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Azad University of Medical Sciences, Dental Branch | Tehran | Tehran Province | Iran |
Not provided
| ID | Term |
|---|---|
| D052016 | Mucositis |
| D014987 | Xerostomia |
| D007239 | Infections |
| D010292 | Paresthesia |
| ID | Term |
|---|---|
| D005759 | Gastroenteritis |
| D005767 | Gastrointestinal Diseases |
| D004066 | Digestive System Diseases |
| D009059 | Mouth Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D009910 | Oral Hygiene |
| D014099 | Toothbrushing |
| C447032 | casein phosphopeptide-amorphous calcium phosphate nanocomplex |
| ID | Term |
|---|---|
| D006920 | Hygiene |
| D013812 | Therapeutics |
| D011313 | Preventive Dentistry |
| D003813 | Dentistry |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Oral Hygiene | Other | Oral hygiene followed. |
|
|
| CPP-ACP | Drug | CPP-ACP paste was applied by patient, once daily. |
|
|
| 6 weeks after first visit |
| Saliva buffering capacity | 6 weeks after first visit |
| D009057 |
| Stomatognathic Diseases |
| D012466 | Salivary Gland Diseases |
| D020886 | Somatosensory Disorders |
| D012678 | Sensation Disorders |
| D009461 | Neurologic Manifestations |
| D009422 | Nervous System Diseases |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |